- Home
- TMP vs NEO Comparison
TMP vs NEO Comparison
Compare TMP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMP | NEO |
|---|---|---|
| Founded | 1836 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TMP | NEO |
|---|---|---|
| Price | $94.54 | $15.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $87.00 | $13.38 |
| AVG Volume (30 Days) | 85.0K | ★ 3.4M |
| Earning Date | 04-24-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 126.16 | N/A |
| EPS | ★ 1.82 | N/A |
| Revenue | ★ $75,742,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $7.94 | $9.73 |
| P/E Ratio | $51.95 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $61.87 | $4.72 |
| 52 Week High | $97.12 | $15.56 |
Technical Indicators
Market Signals| Indicator | TMP | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 83.10 |
| Support Level | $81.09 | $11.49 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.04 | 0.70 |
| MACD | 0.29 | 0.33 |
| Stochastic Oscillator | 74.63 | 92.82 |
Price Performance
Historical ComparisonAbout TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.